Newsroom
April 18, 2025
Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]
January 22, 2025
Since the discovery of antibiotics, physicians have grappled with the inevitability of bacterial resistance to antibiotics. This challenge has become increasingly urgent, with antibiotic resistance projected to cause 39 million deaths between 2025 and 2050, according to the World Health Organization. By 2050, the organization also predicts these infections will surpass cancer as the leading […]
September 30, 2024
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]
September 19, 2024
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]
August 20, 2024
Lack of oxygen can sensitize nerve cells, leading to long-term pain More than 100 million people worldwide are affected by obstructive sleep apnea. This health condition causes a person to stop breathing numerous times while they are sleeping. Reduced sleep time and sleep quality can lead to numerous health problems including obesity, high blood pressure, […]
May 9, 2024
The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant. “We are excited about receiving the U01 award because it will enable us to move […]